Peptide Pen Injector Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Aicare is the best-performing peptide pen injector brand in July 2026, moving 3,000 units across 1 ASIN for 26.3% of Top 10 volume. MIKIROY follows with 2,000 units (17.5%), ahead of Gesanghua on 2,000 units (17.5%).

With 10 brands splitting the Top 10 and 61.4% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $9.99 to $19.99, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B0H2VRS74R booked 200 units at $31.99. On the growth side, B0GL8DFWCZ leads positive momentum with ▲ 100.0% MoM growth on 200 units, with B0F8W831YR close behind at ▲ 28.6% MoM on 900 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.